{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:06:18Z","timestamp":1786118778603,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1097\/hpc.0b013e318053d190","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T00:45:38Z","timestamp":1180053938000},"page":"41-45","source":"Crossref","is-referenced-by-count":5,"title":["Increasing Prevalence of Obesity and Clustered Cardiometabolic Risk: Can Treatment of the Underlying Cause Reverse the Trends?"],"prefix":"10.1097","volume":"6","author":[{"given":"Christie M.","family":"Ballantyne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210126","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1089\/jwh.2006.15.734","article-title":"Recent changes in cardiovascular risk factors among women and men.","volume":"15","author":"Kim","year":"2006","journal-title":"J Womens Health (Larchmt)"},{"key":"R2-1-20210126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.HYP.0000252676.46043.18","article-title":"Prevalence, awareness, treatment, and control of hypertension among United States adults 1999\u20132004.","volume":"49","author":"Ong","year":"2007","journal-title":"Hypertension"},{"key":"R3-1-20210126","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.288.14.1723","article-title":"Prevalence and trends in obesity among US adults, 1999\u20132000.","volume":"288","author":"Flegal","year":"2002","journal-title":"JAMA"},{"key":"R4-1-20210126","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.2337\/diacare.27.10.2444","article-title":"Increasing prevalence of the metabolic syndrome among U.S. adults.","volume":"27","author":"Ford","year":"2004","journal-title":"Diabetes Care"},{"key":"R5-1-20210126","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.2337\/dc06-1136","article-title":"Impact of recent increase in incidence on future diabetes burden: US, 2005\u20132050.","volume":"29","author":"Narayan","year":"2006","journal-title":"Diabetes Care"},{"key":"R6-1-20210126","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/jama.1994.03520030047027","article-title":"Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys, 1960 to 1991.","volume":"272","author":"Kuczmarski","year":"1994","journal-title":"JAMA"},{"key":"R7-1-20210126","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","article-title":"Prevalence of overweight and obesity in the United States, 1999\u20132004.","volume":"295","author":"Ogden","year":"2006","journal-title":"JAMA"},{"key":"R8-1-20210126","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jama.282.16.1519","article-title":"The spread of the obesity epidemic in the United States, 1991\u20131998.","volume":"282","author":"Mokdad","year":"1999","journal-title":"JAMA"},{"key":"R9-1-20210126","first-page":"985","article-title":"State-specific prevalence of obesity among adults\u2014United States, 2005.","volume":"55","author":"Blanck","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R10-1-20210126","article-title":"Healthy People 2010: Understanding and Improving Health.","year":"2000"},{"key":"R11-1-20210126","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/01.CIR.0000116763.91992.F1","article-title":"Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) Study.","volume":"109","author":"Ballantyne","year":"2004","journal-title":"Circulation"},{"key":"R12-1-20210126","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med"},{"key":"R14-1-20210126","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2337\/dc06-0062","article-title":"Prevalence of diabetes and impaired fasting glucose in adults in the US population: National Health and Nutrition Examination Survey 1999\u20132002.","volume":"29","author":"Cowie","year":"2006","journal-title":"Diabetes Care"},{"key":"R15-1-20210126","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"R16-1-20210126","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement.","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"R17-1-20210126","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2337\/diabetes.47.5.699","article-title":"The metabolically obese, normal-weight individual revisited.","volume":"47","author":"Ruderman","year":"1998","journal-title":"Diabetes"},{"key":"R18-1-20210126","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1462-8902.2004.00354.x","article-title":"Characteristics of US adults with the metabolic syndrome and therapeutic implications.","volume":"6","author":"Jacobson","year":"2004","journal-title":"Diabetes Obes Metab"},{"key":"R19-1-20210126","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"National Cholesterol Education Program. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"R20-1-20210126","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"R21-1-20210126","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archinte.163.4.427","article-title":"The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988\u20131994.","volume":"163","author":"Park","year":"2003","journal-title":"Arch Intern Med"},{"key":"R22-1-20210126","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrd2005","article-title":"Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy.","volume":"5","author":"Grundy","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"R23-1-20210126","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/diacare.28.9.2289","article-title":"The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.","volume":"28","author":"Kahn","year":"2005","journal-title":"Diabetes Care"},{"key":"R24-1-20210126","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1161\/CIRCULATIONAHA.106.176583","article-title":"Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association.","volume":"113","author":"Eckel","year":"2006","journal-title":"Circulation"},{"key":"R25-1-20210126","first-page":"80","article-title":"National Institutes of Health\/National Heart, Lung, and Blood Institute, North American Association for the Study of Obesity. The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults.","year":"2000"},{"key":"R26-1-20210126","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMra012586","article-title":"Obesity.","volume":"346","author":"Yanovski","year":"2002","journal-title":"N Engl J Med"},{"key":"R27-1-20210126","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2165\/00003495-200666120-00012","article-title":"Orlistat: a review of its use in the management of obesity.","volume":"66","author":"Henness","year":"2006","journal-title":"Drugs"},{"issue":"suppl 3","key":"R28-1-20210126","first-page":"S12","article-title":"Mode of action of orlistat.","volume":"21","author":"Guerciolini","year":"1997","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R29-1-20210126","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0149-2918(03)90009-9","article-title":"Weight management and current options in pharmacotherapy: orlistat and sibutramine.","volume":"25","author":"Leung","year":"2003","journal-title":"Clin Ther"},{"key":"R30-1-20210126","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/sj.ijo.0802475","article-title":"Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials.","volume":"27","author":"Padwal","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R31-1-20210126","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.27.1.155","article-title":"XENical in the prevention of Diabetes in Obese Subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients.","volume":"27","author":"Torgerson","year":"2004","journal-title":"Diabetes Care"},{"key":"R32-1-20210126","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(97)11509-4","article-title":"Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients.","volume":"352","author":"Sj\u00f6str\u00f6m","year":"1998","journal-title":"Lancet"},{"key":"R34-1-20210126","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/j.1550-8528.1999.tb00701.x","article-title":"Sibutramine produces dose-related weight loss.","volume":"7","author":"Bray","year":"1999","journal-title":"Obes Res"},{"key":"R35-1-20210126","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1001\/archinte.160.14.2185","article-title":"Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial.","volume":"160","author":"McMahon","year":"2000","journal-title":"Arch Intern Med"}],"container-title":["Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/HPC.0b013e318053d190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:41:33Z","timestamp":1786034493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00132577-200706000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/hpc.0b013e318053d190","relation":{},"ISSN":["1535-282X"],"issn-type":[{"value":"1535-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}